S Gastrointestinal And Liver Disease 12th Edition

Updated sections on the GI manifestations of immune checkpoint inhibitors (used in cancer therapy), which have become a critical cause of colitis and hepatitis.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

For over 50 years, Sleisenger and Fordtran's Gastrointestinal and Liver Disease has served as the definitive reference for gastroenterology and hepatology professionals worldwide. The 12th edition (published December 2025) continues this legacy, offering a comprehensive, two-volume masterwork that synthesizes the expertise of hundreds of global leaders to provide up-to-date information on the diagnosis, management, and treatment of gastrointestinal and liver diseases. s gastrointestinal and liver disease 12th edition

In the realm of medical literature, few titles command the respect and authority of Sleisenger and Fordtran . For decades, it has been universally recognized as the "Bible" of gastroenterology. The release of the continues this legacy, offering a comprehensive update to the definitive reference for gastroenterologists, hepatologists, internists, and surgeons. As the field of GI medicine evolves rapidly with new biologics, endoscopic techniques, and genetic discoveries, this text serves as the essential bridge between foundational science and modern clinical practice.

: Extensive new data on biologics and novel small molecules for treating and preventing IBD recurrences. Obesity Management Updated sections on the GI manifestations of immune

The content has been extensively updated to reflect the latest research and clinical guidelines.

I can provide tailored recommendations based on your specific professional or academic needs. In the realm of medical literature, few titles

Inflammatory Bowel Disease (IBD), IBS, and infection.

Detailed summaries of the latest covered in the book